NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF METHYLEUGENOL (CAS NO. 93-15-2) IN F344/N RATS AND B6C3F1 MICE (GAVAGE STUDIES)

NTP Technical Report on the Toxicology and Carcinogenesis Studies Series

Volumn TR-491, Issue , 2000, Pages 1-420

  Abdo, K M ^a   Blumenthal, G M ^a   Bridge, D A ^a   Bucher, J R ^a   Chapin, R E ^a   Haseman, J K ^a   Maronpot, R R ^a   Rao, G N ^a   Roycroft, J H ^a   Smith, C S ^a   Travlos, G S ^a   Witt, K L ^a   Prejean, J D ^a   Manus, A G ^a   Thompson, R B ^a   Hejtmancik, M R ^a   Johnson, J D ^a   Hardisty, J F ^a   Gaillard, E T ^a,c   Morris, R W ^a   McGowan, K P ^a   Mauney, M A ^a   Mintz, N G ^a   Scott, J T ^a   Seely, J C ^a   Hildebrandt, P K ^a   Everitt, J ^b   Hailey, J R ^d   Hard, G C ^e   Herbert, R A ^d   Mahler, J ^d   Nyska, A ^d   Ryan, M J ^f   Sills, R C ^d   Streett, S ^g   Toft, J D ^f   White, H J ^a   Gunnels, S R ^a   Gregan, J A ^a   Harper, L M ^a   Macri Hanson, A M ^a   Serbus, D C ^a   Sharp, W D ^a   Shaw, D P ^a   Swift, S M ^a   Corporation, Dynamac ^a   Brecher, S ^a   more..

^a PATHCO Inc ^*

^b Chemical Industry Institute of Toxicology

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

^d National Toxicology Program

^e American Health Foundation

^f Battelle Columbus Lab   (United States)

^g CS Streett Associates

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85149207941     PISSN: 23788917     EISSN: 23788925     Source Type: Book Series    
DOI: None     Document Type: Review

References (118)

1. Abenoza, P., Manivel, J.C., Wick, M.R., Hagen, K., and Dehner, L.P. (1987). Hepatoblastoma: An immunohistochemical and ultrastructural study. Hum. Pathol. 18, 1025-1035.
2. Allavena, A., Martelli, A., Robbiano, L., and Brambilla, G. (1992). Evaluation in a battery of in vivo assays of four in vitro genotoxins proved to be noncarcinogens in rodents. Teratog. Carcinog. Mutagen. 12, 31-41.
3. Ashby, J., and Tennant, R.W. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257, 229-306.
4. Bailer, A.J., and Portier, C.J. (1988). Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44, 417-431.
5. Battelle Columbus Laboratories (1997). Preliminary chemical study report; methyleugenol palatability study. (NIH No. N01-ES-55395) (G002840-PR); 13 November 1997.
6. Battelle Columbus Laboratories (1998). Special Task Report: Determination of the Partition Coefficient of Methyleugenol. (NIH No. N01-ES-55395) (G002840-UN); 21 July 1998.
7. Beroza, M., Inscoe, M.N., Schwartz, P.H., Jr., Keplinger, M.L., and Mastri, C.W. (1975). Acute toxicity studies with insect attractants. Toxicol. Appl. Pharmacol. 31, 421-429.
8. Bieler, G.S., and Williams, R.L. (1993). Ratio of estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 49, 793-801.
9. Boberg, E.W., Miller, E.C., Miller, J.A., Poland, A., and Liem, A. (1983). Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1N-sulfoxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1N-hydroxysafrole in mouse liver. Cancer Res. 43, 5163-5173.
10. Boorman, G.A., Montgomery, C.A., Jr., Eustis, S.L., Wolfe, M.J., McConnell, E.E., and Hardisty, J.F. (1985). Quality assurance in pathology for rodent carcinogenicity studies. In Handbook of Carcinogen Testing (H.A. Milman and E.K. Weisburger, Eds.), pp. 345-357. Noyes Publications, Park Ridge, NJ.
11. Borchert, P., Wislocki, P.G., Miller, J.A., and Miller, E.C. (1973). The metabolism of the naturally occurring hepatocarcinogen safrole to 1N-hydroxy-safrole and the electrophilic reactivity of 1N-acetoxy-safrole. Cancer Res. 33, 575-589.
12. Brennan, R.J., Kandikonda, S., Khrimian, A.P., DeMilo, A.B., Liquido, N.J., and Schiestl, R.H. (1996). Saturated and monofluoro analogs of the oriental fruit fly attractant methyl eugenol show reduced genotoxic activities in yeast. Mutat. Res. 369, 175-181.
13. Carlini, E.A., Dallmeier, K., and Zelger, J.L. (1981). Methyleugenol as a surgical anesthetic in rodents. Experientia 37, 588-589.
14. Carlini, E.A., de Oliveira, A.B., and de Oliveira, G.G. (1983). Psychopharmacological effects of the essential oil fraction and of the hydrolate obtained from the seeds of Licaria puchury-major. J. Ethnopharmacol. 8, 225-236.
15. Chan, V.S.W., and Caldwell, J. (1992). Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1N-hydroxy metabolites. Food Chem. Toxicol. 30, 831-836.
16. Chemical Carcinogenesis Research Information System (CCRIS) (1998). Maintained, reviewed, and updated on the National Library of Medicine's Data Network (TOXNET). Available through the MEDLARS System.
17. Code of Federal Regulations (CFR) 21, Part 58. Code of Federal Regulations (CFR) 21, § 121.1164.
18. Council of Europe (1974). Natural flavoring substances, their sources, and additional artificial flavoring substances. Partial agreement in the social and public health field, List 1, No. 185. Strasbourg, France.
19. Cox, D.R. (1972). Regression models and life-tables. J. R. Stat. Soc. B34, 187-220.
20. Crawford, B.D. (1985). Perspectives on the somatic mutation model of carcinogenesis. In Advances in Modern Environmental Toxicology. Mechanisms and Toxicity of Chemical Carcinogens and Mutagens (M.A. Mehlman, W.G. Flamm, and R.J. Lorentzen, Eds.), pp. 13-59. Princeton Scientific Publishing Co., Inc., Princeton, NJ.
21. Dallmeier, K., and Carlini, E.A. (1981). Anesthetic, hypothermic, myorelaxant and anticonvulsant effects of synthetic eugenol derivatives and natural analogues. Pharmacology 22, 113-127.
22. Deininger, R., and Wolfe, E. (1977) Germ. Offen. Patent No. 2719623, 18/08/1977.
23. de la Coste, A., Romagnolo, B., Billuart, P., Renard, C-A, Buendia, M-A, Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., and Perret, C. (1998). Somatic mutations of the $-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci USA 95, 8847-8851.
24. Delaforge, M., Janiaud, P., Levi, P., and Morizot, J.P. (1980a). Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxidediol pathway. Xenobiotica 10, 737-744.
25. Delaforge, M., Ioannides, C., and Parke, D.V. (1980b). Ligand binding of safrole to cytochrome P-450. Arch. Toxicol. Suppl. 4, 45-48.
26. Devereux, T.R., Anna, C.H., Foley, J.F., White, C.M., Sills, R.C., and Barrett, J.C. (1999). Mutation of $-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 18, 4726-4733.
27. Dixon, W.J., and Massey, F.J., Jr. (1951). Introduction to Statistical Analysis, 1st ed., pp. 145-147. McGraw-Hill Book Company, Inc., New York.
28. Dunn, O.J. (1964). Multiple comparisons using rank sums. Technometrics 6, 241-252.
29. Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096-1121.
30. Factor, V.M., Radaeva, S.A., and Thorgeirsson, S.S. (1994). Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am. J. Pathol. 145, 409-422.
31. Farm Chemical Handbook (1992). Meister Publishing Co., p. C221, Willoughby, Ohio.
32. Fenaroli's Handbook of Flavor Ingredients (1975). 2nd ed., Vol. 2 (T.E. Furia and N. Bellanca, Eds.), p. 200. The Chemical Rubber Co., Cleveland, Ohio.
33. Fennell, T.R., Miller, J.A., and Miller, E.C. (1984). Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1N-hydroxysafrole and its 1N-oxo metabolite in rats and mice. Cancer Res. 44, 3231-3240.
34. Flavor and Extract Manufacturers Association of the United States (FEMA) (1978). Scientific Literature Review of Eugenol and Related Substances in Flavor Usage. Vol. 1, Accession No. PB 283-501, National Technical Information Service, U.S. Department of Commerce, Washington, DC.
35. Foureman, P., Mason, J.M., Valencia, R., and Zimmering, S. (1994). Chemical mutagenesis testing in Drosophila. IX. Results of 50 coded compounds tested for the National Toxicology Program. Environ. Mol. Mutagen. 23, 51-63.
36. Fox, J.G., MacGregor, J., Shen, Z., Li, X., Lewis, R., and Dangler, C.A. (1999). Role of Helicobacter hepaticus in confounding results of a triethanolamine carcinogenesis study in mice. J. Clin. Microbiol. (in press)
37. Galloway, S.M., Armstrong, M.J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A.D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B.H., Resnick, M.A., Anderson, B., and Zeiger, E. (1987). Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagen. 10 (Suppl. 10), 1-175.
38. Gardner, I., Bergin, P., Stening, P., Kenna, J.G., and Caldwell, J. (1996). Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Chem. Res. Toxicol. 9, 713-721.
39. Gardner, I., Wakazono, H., Bergin, P., de Waziers, I., Beaune, P., Kenna, J.G., and Caldwell, J. (1997). Cytochrome P450 mediated bio-activation of methyleugenol to 1N-hydroxy-methyl-eugenol in Fischer rat and human liver microsomes. Carcinogenesis 18, 1775-1783.
40. Gart, J.J., Chu, K.C., and Tarone, R.E. (1979). Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. JNCI 62, 957-974.
41. Guyton, A.C., and Hall, J.E. (1997). Secretory function of the alimentary tract. In Human Physiology and Mechanisms of Disease, pp. 524-535. W.B. Saunders Company, Philadelphia, PA.
42. Hagan, E.C., Jenner, P.M., Jones, W.I., Fitzhugh O.G., Long E.L., Brouwer, J.G., and Webb, W.K. (1965). Toxic properties of compounds related to safrole. Toxicol. Appl. Pharmacol. 7, 18-24.
43. Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E. (1983). Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen. 5 (Suppl. 1), 3-142.
44. Hayashi, M., Kishi, M., Sofuni, T., and Ishidate, M., Jr. (1988). Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. Food Chem. Toxicol. 26, 487-500.
45. Hays, W.J., Jr., and Laws, E.R., Jr., Eds. (1991). Handbook of Pesticides Toxicology, Vol. 2, pp. 613-614. Academic Press, Inc., San Diego.
46. Hollander, M., and Wolfe, D.A. (1973). Nonparametric Statistical Methods, pp. 120-123. John Wiley and Sons, New York.
47. Howes, A.J., Chan, V.S.W., and Caldwell, J. (1990). Structure-specificity of the genotoxicity of some nat-urally occurring alkenylbenzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes. Food Chem. Toxicol. 28, 537-542.
48. Innes, J.R.M., Ulland, B.M., Valerio, M.G., Petrucelli, L., Hart, E.R., Pallota, A.J., Bates, R.R., Falk, H.L., Gart, J.J., Klein, M., Mitchell, I., and Peters, J. (1969). Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: A preliminary note. J. Natl. Cancer Inst. 42, 1101-1114.
49. Integrated Laboratory Systems (ILS) (1990). Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, P.O. Box 13501, Research Triangle Park, NC 27707.
50. International Agency for Research on Cancer (IARC) (1976). IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Man, Vol. 10. IARC, Lyon, France.
51. Ioannides, C., Delaforge, M., and Parke, D.V. (1981). Safrole: Its metabolism, carcinogenicity, and interactions with cytochrome P-450. Food Cosmet. Toxicol. 19, 657-666.
52. Jiang, Y., Liu-GQ, Ma-Jr, Xie-L, and Wu-Hq (1982). The pharmacological studies on methyleugenol. Yao Hsueh Hsueh Pao 17, 87-92.
53. Johnson, L.R., McCormack, S.A., and Wang, J.V. (1993). Regulation of gastrointestinal mucosal growth. In Gastrin (J.H. Walsh, Ed.), p. 287. Raven Press, New York.
54. Jonckheere, A.R. (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41, 133-145.
55. Kaneko, J.J. (1989). Serum proteins and the dysproteinemias. In Clinical Biochemistry of Domestic Animals (J.J. Kaneko, Ed.), pp. 142-165. Academic Press, Inc., San Diego.
56. Kaplan, E.L., and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
57. Kettering, J.D., and Torabinejad, M. (1995). Investigation of mutagenicity of mineral trioxide aggregate and other commonly used root-end filling materials. J. Endod. 21, 537-542.
58. Lide, D.R., Ed. (1998). CRC Handbook of Chemistry and Physics, 78th ed., pp. 3-42. CRC Press, Inc., Boca Raton, FL.
59. McBride, R.K., Harper, C., and Siegel, I.A. (1987). Methotrexate-induced changes in rat parotid and submandibular gland function. J. Dent. Res. 66, 1445-1448.
60. McConnell, E.E., Solleveld, H.A., Swenberg, J.A., and Boorman, G.A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI 76, 283-289.
61. MacGregor, J.T., Layton, L.L., and Buttery, R.G. (1974). California bay oil. II. Biological effects of constituents. J. Agric. Food Chem. 22, 777-780.
62. MacGregor, J.T., Wehr, C.M., and Langlois, R.G. (1983). A simple fluorescent staining procedure for micronuclei and RNA in erythrocytes using Hoescht 33258 and pyronin Y. Mutat. Res. 120, 269-275.
63. MacGregor, J.T., Wehr, C.M., Henika, P.R., and Shelby, M.D. (1990). The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fundam. Appl. Toxicol. 14, 513-522.
64. 1 mice. Toxicol. Pathol. 25, 606-612.
65. Maronpot, R.R., and Boorman, G.A. (1982). Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol. 10, 71-80.
66. Maronpot, R.R., Giles, H.D., Dykes, D.J., and Irwin, R.D. (1991). Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol. Pathol. 19, 561-570.
67. Maura, A., Pino, A., and Ricci, R. (1989). Negative evidence in vivo of DNA-damaging, mutagenic and chromosomal effects of eugenol. Mutat. Res. 227, 125-129.
68. Miller, E.C., Swanson, A.B., Philips, D.H., Fletcher, T.L., Liem, A., and Miller, J.A. (1983). Structure&activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 43, 1124-1134.
69. Miller, J.A., and Miller, E.C. (1977). Ultimate chemical carcinogens as reactive mutagenic electrophiles. In Origins of Human Cancer (H.H. Hiatt, J.D. Watson, and J.A. Winsten, Eds.), pp. 605-627. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
70. Morrison, D.F. (1976). Multivariate Statistical Methods, 2nd ed., pp. 170-179. McGraw-Hill Book Company, New York.
71. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E. (1986). Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagen. 8 (Suppl. 7), 1-119.
72. Moshonas, M.G., and Shaw, P.E. (1978). Compounds new to essential orange oil from fruit treated with abscisson chemicals. J. Agric. Food Chem. 26, 1288-1290.
73. Myhr, B.C., and Caspary, W.J. (1991). Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: Results for 31 coded compounds in the National Toxicology Program. Environ. Mol. Mutagen. 18, 51-83.
74. National Academy of Sciences (NAS) (1989). 1987 Poundage and Technical Effects Update of Substances Added to Food. Committee on Food Additives Survey Data, Food and Nutrition Board, Institute of Medicine, National Academy of Sciences, Washington, DC.
75. National Cancer Institute (NCI) (1976). Guidelines for Carcinogen Bioassay in Small Rodents. Technical Report Series No. 1. NIH Publication No. 76-801. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, Bethesda, MD.
76. National Institute for Occupational Safety and Health (NIOSH) (1990). National Occupational Exposure Survey (1981-1983), unpublished provisional data as of July 1, 1990. NIOSH, Cincinnati, OH.
77. National Institutes of Health (NIH) (1978). Open Formula Rat and Mouse Ration (NIH-07). Specification NIH-11-1335. U.S. Department of Health, Education, and Welfare, Public Health Service, NIH, Bethesda, MD.
78. 1 Mice (Feed Studies). Technical Report Series No. 223. NIH Publication No. 84-1779. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
79. National Toxicology Program (NTP) (1987). Technical Protocol for Sperm Morphology and Vaginal Cytology Evaluations in Toxicity Testing for Rats and Mice, 10/31/82 version (updated April 1987). Research Triangle Park, NC.
80. Nguyen, H.T. (1989). Specific proteins. C. Transport proteins. In The Clinical Chemistry of Laboratory Animals (W.F. Loeb and F.W. Quimby, Eds.), pp. 176-200. Pergamon Press, Inc., New York.
81. Nonoyama, T., Fullerton, F., Reznik, G., Bucci, T.J., and Ward, J.M. (1988). Mouse hepatoblastomas: A histologic, ultrastructural, and immunohistochemical study. Vet. Pathol. 25, 286-296.
82. Opdyke, D.L.J., Ed. (1979). Monographs on Fragrance Raw Materials, p. 555. Pergamon Press, Inc., New York.
83. 1 mice. Carcinogenesis 5, 1623-1628.
84. Piegorsch, W.W., and Bailer, A.J. (1997). Statistics for Environmental Biology and Toxicology, Section 6.3.2. Chapman and Hall, London.
85. Portier, C.J., and Bailer, A.J. (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol. 12, 731-737.
86. Portier, C.J., Hedges, J.C., and Hoel, D.G. (1986). Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program&s carcinogenicity experiments. Cancer Res. 46, 4372-4378.
87. Poynter, D., and Selway, S.A.M. (1991). Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach. Mutat. Res. 248, 303-319.
88. Sadtler Pharmaceuticals Grating Spectra (1974). IR No. R421. Sadtler Research Laboratories, Inc., Philadelphia.
89. Sadtler Standard Spectra. IR No. 17520; UV No. 5557; NMR No. 4257M. Sadtler Research Laboratories, Inc., Philadelphia.
90. Sax's Dangerous Properties of Industrial Materials (1992). 8th ed. (R.J. Lewis, Sr., Ed.), pp. 2435-2437. Van Nostrand Reinhold, New York.
91. Schiestl, R.H., Chan, W.S., Gietz, R.D., Mehta, R.D., and Hastings, P.J. (1989). Safrole, eugenol, and methyleugenol induce intrachromosomal recombination in yeast. Mutat. Res. 224, 427-436.
92. Sekizawa, J., and Shibamoto, T. (1982). Genotoxicity of safrole-related chemicals in microbial test systems. Mutat. Res. 101, 127-140.
93. Sell, S., and Dunsford, H.A. (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am. J. Pathol. 134, 1347-1363.
94. Seto, T.A., and Keup, K. (1969). Effects of alkylmethoxybenzene and alkylmethylenedioxybenzene essential oils on pentobarbital and ethanol sleeping time. Arch. Int. Pharmacodyn. 180, 232-240.
95. Shelby, M.D., and Witt, K.L. (1995). Comparison of results from mouse bone marrow chromosome aberration and micronucleus tests. Environ. Mol. Mutagen. 25, 302-313.
96. Shelby, M.D., Erexson, G.L., Hook, G.J., and Tice, R.R. (1993). Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ. Mol. Mutagen. 21, 160-179.
97. Shirley, E. (1977). A non-parametric equivalent of Williams' test for contrasting increasing dose levels of a treatment. Biometrics 33, 386-389.
98. Sims, P., and Grover, P.L. (1974). Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. In Advances in Cancer Research (G. Klein, Ed.), Vol. 20, pp. 165-274. Academic Press, New York.
99. Sofuni, T., Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K.I., Nishi, Y., and Nakadate, M. (1996). Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the microwell method: Interim report of an international collaborative study. Mutagenesis 11, 349-355.
100. Solheim, E., and Scheline, R.R. (1976). Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers. Xenobiotica 6, 137-150.
101. SRI International (1990). Directory of Chemical Producers, United States of America, pp. 8, 291, 292, 391, and 654. Menlo Park, CA.
102. Stillwell, W.G., Carman, M.J., Bell L., and Horning, M.G. (1974). The metabolism of safrole and 2N,3N-epoxysafrole in the rat and guinea pig. Drug Metab. Dispos. 2, 489-498.
103. Stocker, J.T. (1994). Hepatoblastoma. Semin. Diagn. Pathol. 11, 136-143.
104. Stofberg, J., and Grundschober, F. (1987). Consumption ratio and food predominance of flavoring materials. Perfumer and Flavorist 12, 27.
105. Straus, D.S. (1981). Somatic mutation, cellular differentiation, and cancer causation. JNCI 67, 233-241.
106. Takahashi, M., Fukuda, K., Sugimura, T., and Wakabayashi, K. (1998). $-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res. 58, 42-46.
107. Tarone, R.E. (1975). Tests for trend in life table analysis. Biometrika 62, 679-682.
108. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236, 933-941.
109. Thake, D.C., Iatrapoulos, M.J., Hard, G.C., Hotz, K.J., Wang, C.-X., Williams, G.M., and Wilson, A.G.E. (1995). A study of the mechanism of butachlor-associated gastric neoplasms in Sprague-Dawley rats. Exp. Toxicol. Pathol. 47, 107-116.
110. Turusov, V.S., Deringer, M.K., Dunn, T.B., and Stewart, H.L. (1973). Malignant mouse-liver tumors resembling human hepatoblastomas. J. Natl. Cancer Inst. 51, 1689-1695.
111. van Eyken, P., Sciot, R., Callea, F., Ramaekers, F., Schaart, G., and Desmet, V.J. (1990). A cytokeratinimmunohistochemical study of hepatoblastoma. Hum. Pathol. 21, 302-308.
112. Wagner, H. (1980). Pharmazeutische Biologie, Drogen und ihre Inhaltstoffe.
113. Weast, R.C., Ed. (1982). CRC Handbook of Chemistry and Physics, 62nd ed. CRC Press, Inc., Boca Raton, FL.
114. Williams, D.A. (1971). A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27, 103-117.
115. Williams, D.A. (1972). The comparison of several dose levels with a zero dose control. Biometrics 28, 519-531.
116. Woolverton, C.J., Fotos, P.G., Mokas, M.J., and Mermigas, M.E. (1986). Evaluation of eugenol for mutagenicity by the mouse micronucleus test. J. Oral Pathol. 15, 450-453.
117. World Health Organization (WHO) (1981). Evaluation of Certain Food Additives and Contaminants. Twenty-sixth Report of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series 669, pp. 92-94. WHO, Geneva, Switzerland.
118. Zeiger, E., Haseman, J.K., Shelby, M.D., Margolin, B.H., and Tennant, R.W. (1990). Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen. 16 (Suppl. 18), 1-14.